GlassScriptPhysician profile
Sharon Weber
NPI 1528597291
$3,633.54
in general payments reported to CMS, 2019-2025
38 companies · $814 in 2025
The $814 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $533 · 2022: $1,019 · 2023: $582 · 2024: $686 · 2025: $814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,082.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,081.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $378.91 | 2021-2023 | Erleada |
| Corcept Therapeutics | $236.36 | 2024-2025 | Korlym |
| Abbvie INC. | $230.44 | 2022-2023 | |
| 180 Medical, INC. | $215.98 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $165.15 | 2021-2025 | Capvaxive, Gardasil 9, Gardasil |
| Lilly USA, LLC | $165.02 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Urovant Sciences INC | $163.72 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $158.04 | 2021-2023 | Xiaflex |
| Qol Medical, LLC | $148.81 | 2023-2025 | Sucraid, Sucraid |
| Novo Nordisk INC | $146.67 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Boston Scientific Corporation | $137.96 | 2025 | Axios |
| Teleflex LLC | $136.50 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $132.72 | 2022-2024 | |
| Astellas Pharma US INC | $121.52 | 2021-2023 | Myrbetriq |
| Olympus America INC. | $112.59 | 2021-2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.